Brussels pays €63 million to ensure Remdesivir treatments

in News · 01-08-2020 18:00:00 · 2 Comments
Brussels pays €63 million to ensure Remdesivir treatments

The European Commission has announced that it has signed a €63 million contract with the pharmaceutical company Gilead to ensure treatments with Remdesivir in the European Union (EU), after this antiviral medicine was authorised to fight Covid -19.

According to the information released by the community executive, this contract signed with Gilead, after talks with the company in recent weeks, aims to “guarantee treatment doses of Veklury, the trademark of Remdesivir”, which is considered to be the “ first drug authorised at EU level for the treatment of covid-19”.

Thus, "from the beginning of August, and in order to meet immediate needs, lots of Veklury will be made available to Member States and the United Kingdom, with the coordination and support of the Commission", adds the European Commission.

Budgeted at €63 million financed by the European Commission's Emergency Support Instrument, the measure aims to guarantee the treatment of about 30,000 patients who have severe symptoms of Covid-19, according to the institution's estimates.

"This will help to cover current needs over the next few months, while ensuring fair distribution at EU level, based on a distribution key, taking into account the recommendations of the European Centre for Disease Prevention and Control", explains the European Union Commission.

The community executive is now preparing for a joint acquisition for new 'stocks' of the drug to cover additional needs and supplies from October.

In early July, Remdesivir was authorised by the European Medicines Agency (EMA) as the first treatment for Covid-19, aiming to cure adults and adolescents from 12 years of age with pneumonia that require supplemental oxygen.

As long as it is authorised to be marketed for the treatment of Covid-19 in the EU, the drug continues to be monitored to ensure its safety.

Gilead was also asked to submit final reports of the Remdesivir studies to the EMA by the end of the year, which is one of the conditions to be met in order to move from a conditional marketing authorisation to a full authorisation.


Comments:

Even if you eat an organic diet and exercise, you will still eventually die. You might even get hit by a bus while out jogging or riding a bike. You will just die healthier, that's all. Don't forget, there are a lot of sick people in health food stores!

by William from Other on 03-08-2020 11:30:00

63 million euros / 30,000 = €2100 a patient! Most of whom are 80+yrs! and have self/age related health issues.
Gilead?? will produce the "how great Remdesivir is" report!!
"Double Blind" independent testing - oldschool eh?

If the cure was maintaining your health with organic diet and exercises, do you think they would tell us?

Love Steve.

by Love Steve from Alentejo on 01-08-2020 10:06:00
Interactive Topics, send us your comments/opinion on this article.

Please note that The Portugal News may use selected comments in the printed edition of the newspaper.